Briefing
ctDNA for recurrence detection in high-risk resected melanoma
Observational study using serial ctDNA to infer recurrence risk in stage III and limited stage IV melanoma. ClinicalTrials.gov lists the study as completed.
- Design: Not applicable · Completed